Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Gains from Investment Securities (2023 - 2025)

Fractyl Health's Gains from Investment Securities history spans 3 years, with the latest figure at -$24.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 1848.22% year-over-year to -$24.5 million, compared with a TTM value of -$33.6 million through Dec 2025, down 318.65%, and an annual FY2025 reading of $3.2 million, down 68.53% over the prior year.
  • Gains from Investment Securities for Q4 2025 was -$24.5 million at Fractyl Health, down from $2.4 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $3.0 million in Q3 2024, with the low at -$24.5 million in Q4 2025.
  • Average Gains from Investment Securities over 3 years is -$1.7 million, with a median of $1.2 million recorded in 2023.
  • Biggest YoY gain for Gains from Investment Securities was 46633.33% in 2024; the steepest drop was 522400.0% in 2024.
  • Tracing GUTS's Gains from Investment Securities over 3 years: stood at $3000.0 in 2023, then surged by 46633.33% to $1.4 million in 2024, then crashed by 1848.22% to -$24.5 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Gains from Investment Securities are -$24.5 million (Q4 2025), $2.4 million (Q3 2025), and $2.3 million (Q2 2025).